Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001085146-25-005108·Kynam Capital Management, LP
Schedule 13G ownership disclosure
Vera Therapeutics Inc
Class A common stock, $0.001 par value per share · CUSIP: 92337R101
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Kynam Capital Management, LP
Shares: 3,426,887 · Class: 5.37%
- Kynam Capital Management GP, LLC
Shares: 3,426,887 · Class: 5.37%
- Yue Tang
Shares: 3,426,887 · Class: 5.37%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-005108
- Form type
- SCHEDULE 13G
- Filer
- Kynam Capital Management, LP
- CIK
- CIK 1907884
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership